Yomna Moqidem
PIPS Host Organisation: GSK, Stevenage
PIPS Project Title: Clonal ranking of engineered CHO cell lines in a pseudo-perfusion Ambr 15 bioprocess
Yomna spent her PIPS placement in the upstream bioprocessing and cell line selection team at GSK Stevenage. The team develops and optimises the processes used to produce therapeutic monoclonal antibodies at scale. Coming from a PhD in cell biology, this was Yomna’s first real exposure to bioprocessing. Her main project was to rank a panel of engineered CHO cell lines expressing a therapeutic protein, using a pseudo-perfusion process in Ambr 15 bioreactors. She and the team compared growth, viability, product yield and metabolic profiles to identify the top-ranked cell lines for scale-up. Working alongside chemical engineers taught her to adapt quickly to a new discipline, and she learned how a regulated environment handles documentation and data confidentiality. Beyond the training, Yomna attended a series of seminars, talks and poster presentations, and built connections with colleagues across different departments.
The whole placement has changed how Yomna thinks about her PhD research. She now asks what a finding would need in order to move towards a product, not only whether it is true. She also learned how scientific decisions in industry are weighed against yield, cost, scalability and what manufacturing can deliver. Yomna is grateful to her PIPS host, Chris Spencer, and the team for their time and support, and to SoCoBio for making this opportunity possible.